Supernus Pharmaceuticals Inc logo

Supernus Pharmaceuticals Inc

NEW
LTS:0LB2 (USA)  
$ 48.56 +0.74 (+1.55%) Jul 28
At Loss
P/B:
2.57
Market Cap:
$ 2.77B
Enterprise V:
$ 2.43B
Volume:
19.00
Avg Vol (2M):
27.00
Trade In:
Volume:
19.00
At Loss
Avg Vol (2M):
27.00

Supernus Pharmaceuticals Inc Valuation Measures